Tesla (TSLA) and SpaceX (SPCX) will need far more chips than current and future global production can supply, and SPCX announces that Terafab will be built in Texas
Newsquawk Staff ·
Tesla (TSLA) and SpaceX (SPCX) will need far more chips than current and future global production can supply, and SPCX announces that Terafab will be built in Texas.
What it means
Claims that demand will outrun global chip supply sit in a long tradition of shortage narratives around semiconductors, and past episodes of this kind have tended to resolve through capacity additions that eventually overshoot, turning scarcity into glut within a few years. The announcement of a new fab in Texas follows the established pattern of onshoring incentives pulling large fab commitments into the US, where the gap between announcement, construction, and actual output has historically been measured in years and subject to cost escalation. The actors matter here: both companies share a common controlling figure, and self-reported demand projections from an interested party have tended to run ahead of realised orders in comparable announcements. The operative transmission channels are foundry pricing power, leading-edge versus mature-node allocation, and the equipment and materials chain that fills order books well before wafer output arrives. Worth watching is whether the project carries external anchor customers or government support, since fabs built against a single captive buyer have a weaker track record than those with diversified offtake, and whether committed capital and tooling orders follow the announcement.
- Instacart (CART) is reportedly exploring a sale, The Information reports; held talks with DoorDash (DASH) and Uber (UBER)
- US FDA approves subcutaneous induction regimen for AbbVie’s (ABBV) Skyrizi for adults with moderately to severely active Crohn’s disease
- Kimi K3.1 Pro AI model builds GTA VI-style (TTWO) playable game demo in just 10 hours for USD 52, developer claims on X; showcases AI’s ability to generate video game experiences - UNCONFIRMED
- OpenAI expects future AI models to be capable of identifying and exploiting vulnerabilities that are currently unknown, according to a blog post
- Texas Attorney General Ken Paxton sues OpenAI and CEO Sam Altman for lying to users and harming Texans
Related headlines
- Daily US Earnings Estimates: 26th October 2026: VZ, WELL12 hours ago
- Moonshot AI unveils 2.8tln-parameter Kimi K3.1 Pro model; says it beats Opus 5.5 and GPT-6 Astra on long-horizon coding tasks and scores top marks on SWE Marathon and agent benchmarks; pledges open weights for the 3tln-class model by November 4th12 hours ago
- The Trump administration plans to introduce voluntary “US Caught Seafood” labels to help consumers identify seafood origins, according to CBS14 hours ago
- Bristol Myers Squibb (BMY) spokesperson says the company has identified the cause of an earlier Car-T safety signal; will look to resume the paused trials in 202714 hours ago
- OpenAI reveals plans for an in-house exabyte-scale storage system14 hours ago
- Republican Senator Blackburn has raised concerns about Meta’s (META) plans to update its commercial terms, warning that the changes could “exploit American creators and businesses,” according to a letter14 hours ago
- Upside in Penguin Solutions (PEGN) attributed to M&A chatter - UNCONFIRMED 14 hours ago
- CrowdStrike (CRWD) CEO says in the coming months we will see a lot of breaches from the PHP vulnerability14 hours ago
- US President Trump says Elon Musk will not do anything wrong regarding access to Starlink (SPCX) in Ukraine15 hours ago
- CNBC speculates that Verizon (VZ) would most likely be involved in the context of a partnership with SpaceX (SPCX)15 hours ago
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed15 hours ago
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce16 hours ago
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders16 hours ago
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer17 hours ago
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation17 hours ago